Immuron (IMRN) Capital Expenditures (2016 - 2022)
Immuron (IMRN) recorded quarterly Capital Expenditures of -$7067.0 in Q4 2022, down 45.61% quarter-over-quarter from -$4853.3 in Q4 2021, and down 45.61% on a YoY basis from -$12993.9 in Q4 2021.
Immuron (IMRN) Capital Expenditures (2016 - 2022) Analysis & Trends
Immuron's Capital Expenditures history runs 6 years deep, the most recent figure standing at -$7067.0 for Q4 2022.
- In Q4 2022, Capital Expenditures fell 45.61% year-over-year to -$7067.0; the TTM figure through Dec 2022 stood at -$19414.3 (down 38.22% YoY), while the FY2025 annual figure was -$3.0 million, down 1556965.64% from the prior year.
- Capital Expenditures was -$7067.0 for Q4 2022 at Immuron, down from -$4853.3 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of -$864.0 in Q4 2019 to a low of -$7067.0 in Q4 2022.
- Historically, Capital Expenditures has averaged -$4853.6 across 4 years, with a median of -$5741.6 in 2020.
- The sharpest annual moves came in 2020 and 2021: Capital Expenditures plunged 667.36% in 2020, then gained 26.8% in 2021.
- A 4-year view of Capital Expenditures shows it stood at -$864.0 in 2019, then slumped by 667.36% to -$6630.0 in 2020, then gained by 26.8% to -$4853.3 in 2021, then plunged by 45.61% to -$7067.0 in 2022.
- The last three Capital Expenditures figures came in at -$7067.0 (Q4 2022), -$4853.3 (Q4 2021), and -$6630.0 (Q4 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -63,220.27 |
| 10 | Immuron | 921.61 Mn | 921.58 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -7,067.00 |
| Dec 31, 2022 | -7,067.00 |
| Dec 31, 2021 | -4,853.28 |
| Dec 31, 2021 | -4,853.28 |
| Dec 31, 2020 | -6,630.00 |
| Dec 31, 2020 | -6,630.00 |
| Dec 31, 2019 | -864.00 |
| Dec 31, 2019 | -864.00 |
| Dec 31, 2017 | -1,698.97 |
| Dec 31, 2017 | -1,698.97 |
| Dec 31, 2016 | 1,416.72 |
| Dec 31, 2016 | 1,416.72 |